HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kelly, R. A. Articles by Smith, T. W. Search for Related Content PubMed PubMed Citation Articles by Kelly, R. A. Articles by Smith, T. W. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 261, Issue 25, 11704-11711, 09, 1986

Identification of NaK-ATPase inhibitors in human plasma as nonesterified fatty acids and lysophospholipids

RA Kelly, DS O'Hara, WE Mitch and TW Smith

Elevated plasma levels of factors with cardiac glycoside-like activity have been implicated in the response to volume expansion in animals and in the pathogenesis of certain human diseases. We recently described four fractions (IR1, EI1, EI2, EI3) from normal human plasma that inhibit NaK-ATPase, displace ouabain from the enzyme, and exhibit digoxin-like immunoreactivity (Kelly, R. A., O'Hara, D. S., Canessa, M. L., Mitch, W. E., and Smith, T. W. (1985) J. Biol. Chem. 260, 11396- 11405). In this report, we identify the active component of these plasma fractions as long-chain nonesterified fatty acids (NEFA) and lysophospholipids. These lipids were present in fractions EI1, EI2, and EI3 in quantities sufficient to account for all of the NaK-ATPase inhibitory activity. The digoxin-like immunoreactivity in fraction IR1 could be attributed to hydrocortisone and other endogenous steroids. To explore the nature of the lipid-NaK-ATPase interactions, we examined the effects of various ATP or sodium concentrations on the NaK-ATPase activity measured in the presence of NEFA. Varying sodium did not affect the inhibition of NaK-ATPase by linoleic acid. At less than 0.15 mM ATP, linoleic acid stimulated NaK-ATPase, but at higher ATP concentrations, the enzyme was progressively inhibited. In summary, NEFA and lysophospholipids, at levels similar to those occurring in human plasma, may account for all of the NaK-ATPase inhibitory activity observed in human plasma fractions. These lipids probably do not directly regulate NaK-ATPase in vivo under normal physiologic conditions, but may alter the sodium pump in disease states characterized by abnormalities in lipid metabolism or plasma protein binding.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. M. Corbi, S. Carbone, P. Ziccardi, G. Giugliano, R. Marfella, F. Nappo, G. Paolisso, K. Esposito, and D. Giugliano FFAs and QT Intervals in Obese Women with Visceral Adiposity: Effects of Sustained Weight Loss Over 1 Year J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2080 - 2083. [Abstract] [Full Text] [PDF]

				R. Marfella, L. De Angelis, F. Nappo, D. Manzella, M. Siniscalchi, G. Paolisso, and D. Giugliano Elevated plasma fatty acid concentrations prolong cardiac repolarization in healthy subjects Am. J. Clinical Nutrition, January 1, 2001; 73(1): 27 - 30. [Abstract] [Full Text] [PDF]

				G. Paolisso, D. Manzella, M. R. Rizzo, E. Ragno, M. Barbieri, G. Varricchio, and M. Varricchio Elevated plasma fatty acid concentrations stimulate the cardiac autonomic nervous system in healthy subjects Am. J. Clinical Nutrition, September 1, 2000; 72(3): 723 - 730. [Abstract] [Full Text] [PDF]

				R. A. Rabini, P. Fumelli, G. Zolese, E. Amler, E. Salvolini, R. Staffolani, N. Cester, and L. Mazzanti Modifications Induced by Plasma from Insulin-Dependent Diabetic Patients and by Lysophosphatidylcholine on Human Na+,K+-Adenosine Triphosphatase J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2405 - 2410. [Abstract] [Full Text]

				A. Wang, R. Loo, Z. Chen, and E. A. Dennis Regiospecificity and Catalytic Triad of Lysophospholipase I J. Biol. Chem., August 29, 1997; 272(35): 22030 - 22036. [Abstract] [Full Text] [PDF]

				A. Wang, R. A. Deems, and E. A. Dennis Cloning, Expression, and Catalytic Mechanism of Murine Lysophospholipase I J. Biol. Chem., May 9, 1997; 272(19): 12723 - 12729. [Abstract] [Full Text] [PDF]

				R. J. Grekin, A. P. Vollmer, and R. S. Sider Pressor Effects of Portal Venous Oleate Infusion : A Proposed Mechanism for Obesity Hypertension Hypertension, July 1, 1995; 26(1): 193 - 198. [Abstract] [Full Text]

				R. Hammerton, K. Krzeminski, R. Mays, T. Ryan, D. Wollner, and W. Nelson Mechanism for regulating cell surface distribution of Na+,K(+)-ATPase in polarized epithelial cells Science, November 8, 1991; 254(5033): 847 - 850. [Abstract] [PDF]